MALE REPRODUCTIVE ORGANS
2.Seki N, Senoh K, Kubo S, Tsunoda T. Congenital megalourethra: a case report. Int J Urol 1998;5:191– 193.
3.Aggarwal A, Krishnan J, Kwart A, Perry D. Noonan’s syndrome and seminoma of undescended testicle. South Med J 2001;94:432–434.
4.Nicolas F, Dubois R, Laboure S, Dodat H, Canterino I, Rouviere O. [Testicular microlithiasis and cryptorchism: ultrasound analysis after orchidopexy.] [French] Prog Urol 2001;11:357–361.
5.Lam WW, Tam PK, Ai VH, Chan KL, Chan FL, Leong L. Using gadolinium-infusion MR venography to show the impalpable testis in pediatric patients. AJR 2001;176:1221–1226.
6.Robert F, Rollet J, Lapray JF, Bey-Omar F, Durieu I, Morel Y. [Agenesis of the vas deferens in male infertility. A tentative classification based on 39 cases.] [French] Presse Med 1999;28:116–121.
7.Stikkelbroeck NM, Suliman HM, Otten BJ, Hermus AR, Blickman JG, Jager GJ. Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features. Eur Radiol 2003;13:1597–1603.
8.Avila NA, Premkumar A, Merke DP. Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings. AJR 1999;172:1003–1006.
9.Goldman SM, Sandler CM, Corriere JN Jr, McGuire EJ. Blunt urethral trauma: a unified, anatomical mechanical classification. [Review] J Urol 1997;157:85– 89.
10.Uder M, Gohl D, Takahashi M, et al. MRI of penile fracture: diagnosis and therapeutic follow-up. Eur Radiol 2002;12:113–120.
11.Dee KE, Deck AJ, Waitches GM. Intratesticular pseudoaneurysm after blunt trauma. AJR 2000;174: 1136.
12.Frauscher F, Klauser A, Stenzl A, Helweg G, Amort B, zur Nedden D. Ultrasonography findings in the scrotum of extreme mountain bikers. Radiology 2001;219:817–821.
13.Mueller-Lisse UG, Frimberger M, Schneede P, Heuck AF, Muschter R, Reiser MF. Perioperative prediction by MRI of prostate volume six to twelve months after laser-induced thermotherapy of benign prostatic hyperplasia. J Magn Reson Imaging 2001; 13:64–68.
14.Shukla-Dave A, Hricak H, Eberhardt SC, et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings–initial observations. Radiology 2004;231:717–724.
15.Tisseau L, Zini L, Lemaitre L, Biserte J, Gosselin B, Leroy X. [Prostatic malacoplakia: report of 3 cases.] [French] Prog Urol 2000;10:597–599.
16 Halpern EJ, Hirsch IH. Sonographically guided transurethral laser incision of a Mullerian duct cyst for treatment of ejaculatory duct obstruction. AJR 2000;175:777–778.
17.Francica G, Bellini S, Miragliuolo A. Schwannoma of the prostate: ultrasonographic features. Eur Radiol 2003;13:2046–2048.
18.Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sozen S, Gill H. Histological and clinical findings in 896 consecutive prostates treated only with radical retrop-
ubic prostatectomy: epidemiologic significance of annual changes. J Urol 1998;160:2412–2417.
19.Villers A, Soulie M, Haillot O, Boccon-Gibod L. [Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers.] [Review] [French] Prog Urol 1997;7: 655–661.
20.Vantaux P, Schneider P, Le Coz S, Villers A. [Consumption coagulopathy disclosing prostatic cancer.] [French] Prog Urol 2001;11:68–69.
21.Valeri A, Drelon E, Azzouzi R, et al. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies.] [French] Prog Urol 1999;9:672–679.
22.Hoedemaeker RF, van der Kwast TH, Boer R, et al. Pathologic features of prostate cancer found at popu- lation-based screening with a four-year interval. J Natl Cancer Inst 2001;93:1153–1158.
23.Hugosson J, Aus G, Becker C, et al. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden. BJU Int 2000;85:1078–1084.
24.Benchekroun A, Zannoud M, Ghadouane M, Alami M, Belahnech Z, Faik M. [Sarcomatoid carcinoma of the prostate.] [Review] [French] Prog Urol 2001;11:327– 330.
25.Lilleby W,Torlakovic G,Torlakovic E,Skovlund E,Fossa SD. Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy. Cancer 2001;92:311–319.
26.Rubin MA, Dunn R, Kambham N, Misick CP, O’Toole KM. Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy? Am J Surg Pathol 2000;24:1634–1640.
27Bocking A. [Cytopathology of the prostate.] [Review] [German] Pathologe 1998;19:53–58.
28.Prando A, Wallace S. Helical CT of prostate cancer: early clinical experience. AJR 2000;175:343–346.
29.Halpern EJ, Strup SE Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR 2000;174:623–627.
30.Kuligowska E, Barish MA, Fenlon HM, Blake M. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology 2001;220:757–764.
31.Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast-enhanced US for detection. Radiology 2001; 219:219–225.
32.Lagalla R, Caruso G, Urso R, Bizzini G, Marasa L, Miceli V. [The correlations between color Doppler using a contrast medium and the neoangiogenesis of small prostatic carcinomas.] [Italian] Radiol Med 2000;99: 270–275.
33.Ikonen S, Karkkainen P, Kivisaari L, et al. Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 1998;159:915–919.
34.Cruz M, Tsuda K, Narumi Y, et al. Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 2002;12:357–365.
35.Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton